The FDA has rejected Verily's Parkinson's disease-focused clinical trial tool designed to evaluate the effectiveness of certain interventions, on the premise that it has limited ability to capture the full picture of a patient's capacities.
The tool, dubbed the Virtual Motor Exam for Parkinson's disease, runs on the FDA-cleared Verily Study Watch and was designed to digitally assess a patient's...
Eugene Borukhovich, COO of YourCoach, former global head of digital health at Bayer and cohost of the podcast "A Shot of Digital Health Therapy" joins HIMSSCast for a wide-ranging discussion about his career and his unique perspective on digital health and health innovation. Be sure to check out host Jonah Comstock's appearance on Eugene's podcast as well.
Like what you hear? Subscribe to the...
Pakistani online pharmacy Dawaai has announced that it raised $8.5 million in a recent investing round led by US-based 500 Startups and participated by local venture capital firm Sarmayacar. Kingsway Capital, Crimson Seed Capital and Mentors Fund also took part in the round.
WHY IT MATTERS
Launched in 2014, Dawaai is touted to be Pakistan's largest pharmaceutical marketplace that offers authentic...
The pharma world is notoriously slow moving, taking years to develop a molecule. Meanwhile digital health companies are often working at breakneck speed to innovate. This is just one of the many culture gaps the pair encounter working together, according to digital innovation vet Naomi Fried.
This morning, Fried and pharmaceutical exec Laura Gunn announced a new accelerator, dubbed PharmStars, ...
Digital health has the potential to transform the pharmaceutical industry and the patient experience. Both digital health startups and pharma are eager to engage each other. Pharma continues to have significant need to leverage innovative "beyond the pill solutions."
Digital health startups offer a wealth of potential solutions, and investors have noticed. Such startups attracted over $6.7...
The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field – now generally referred to as "decentralized clinical trials" – has been advancing and gaining traction ever since. But, like so many other remote tools, it's been greatly accelerated by the COVID-19 pandemic.
On today's HIMSSCast, host Jonah Comstock and MobiHealthNews Managing Editor Laura...
Kaiku Health, maker of an oncology-focused platform that collected patient-reported outcomes, is teaming up with pharma giant Novartis on a new initiative to help monitor and manage melanoma.
The companies will zero in on creating a remote monitoring and support network for patients receiving a specific drug combination, known as BRAF and MEK inhibitors, that aims to treat melanoma. As part of...
Silicon Valley giant NVIDIA is teaming up with pharma company AstraZeneca and the University of Florida on new artificial intelligence research projects aimed at boosting drug discovery and patient care.
This morning NVIDIA and AstraZeneca revealed a new drug-discovery model called MegaMoIBART, which is aimed at "reaction prediction, molecular optimization and de novo molecular generation."...
Digital therapeutics company Pear Therapeutics is looking to integrate digital biomarkers, machine learning algorithms and sensor-based technologies into its platform thanks to new licensing deals and partnerships.
The Boston-based DTx company has inked collaboration deals with Empatica and etectRx, as well as licensing tech from KeyWise.
Specifically, Pear's collaboration with Empatica will...
Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences.
The startup and its CEO Ed Cox became one of the developing space's many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer's symptoms treatment, with Cox chairing a handful of industry...
.JPG?itok=KiNiljZx)
